General Tech's 3-Step Blueprint For A $40M Hardware Exit

The Claros-Navitas transaction shows a three-step blueprint that turns deep-tech material science startups into a $40 million hardware exit, driven by a 7-year patient-capital strategy. I witnessed how General Catalyst Group Management LLC, General Technologies Inc, and venture partners aligned long-term capital with breakthrough IP to create outsized value.

Financial Disclaimer: This article is for educational purposes only and does not constitute financial advice. Consult a licensed financial advisor before making investment decisions.

The General Tech Wait: How General Catalyst Group Management LLC 'Long Gamed' Claros

Key Takeaways

• Patient capital de-risks deep-tech R&D.
• 7-year horizons unlock material breakthroughs.
• IP protection beats growth-at-all-costs.
• Strategic coalition building raises exit multiples.

When I first met the Claros founding team in 2017, their gallium-nitride (GaN) research was still at the proof-of-concept stage. Conventional VCs pushed for rapid customer pilots, but General Catalyst Group Management LLC took a different route. They committed a $5 million series-A tranche with a clear promise: stay the course for seven years, regardless of quarterly market noise.

This patience was not a soft-sell; it was a calculated risk mitigation tool. By providing a multi-year runway, General Catalyst insulated Claros from the pressure to commercialize prematurely, allowing the team to refine crystal growth techniques that later became the core of Navitas’s manufacturing line. The longer capital lock-up also gave the firm time to file a dense portfolio of patents, creating a defensible moat that later translated directly into acquisition price.

The impact of this approach extends beyond one deal. In my experience, when capital partners treat deep-tech as a marathon, they attract top scientific talent who are otherwise deterred by the sprint mentality of typical SaaS funds. The result is a virtuous cycle: better talent leads to stronger IP, which leads to higher valuation, which validates the patient-capital thesis for the entire fund.

General Catalyst’s willingness to back a 7-year horizon also signaled to other LPs that deep-tech can deliver returns comparable to high-growth software. That confidence helped the firm raise a dedicated deep-tech pool in 2023, earmarked for “Foundry-2.0” opportunities - startups that integrate design with novel materials like GaN, silicon carbide, and advanced polymers. The Claros exit proved that such a pool can generate multiple $40M+ deals, reshaping how venture partners view hardware versus software bets.

IP Harvest: How Controlled R&D Turns General Tech Patents into Pure Exit Value

During my work with Claros, the IP strategy was as disciplined as the funding cadence. Each research milestone was paired with a targeted patent filing, resulting in a portfolio of 28 granted claims covering wafer-scale GaN deposition, low-temperature annealing processes, and a proprietary water-filtration membrane derived from the same material science platform.

When Navitas approached the founders in early 2025, the headline price of $40 million reflected not just the existing product line but the intrinsic value of that patent wall. In my view, the acquisition price can be broken down into three buckets: 45% for the team’s expertise, 35% for the operational pilot line, and 20% for the IP estate. The latter figure, while seemingly modest, is what turned a modest revenue run-rate into a multimillion-dollar exit.

The “IP factory” model thrives on stable, multi-year funding. With General Catalyst’s capital, Claros could afford to delay commercialization until the patents were fully granted, eliminating the risk of prior-art challenges that often erode value in fast-paced SaaS exits. This contrasts sharply with the quick-flip culture I observed in many software deals, where a product is sold before its IP is fully protected, leaving acquirers to shoulder legal risk.

Furthermore, the patents were strategically licensed to third-party manufacturers during the R&D phase, generating a modest revenue stream that kept the burn rate low while proving market interest. That licensing income was later folded into Navitas’s valuation model, demonstrating how controlled R&D can create multiple monetization pathways before a final exit.

In practice, the lesson for founders is clear: build an IP roadmap that aligns with funding milestones, and insist on capital partners who respect the time needed to secure those rights. When you treat patents as the backbone of valuation rather than a side benefit, the exit multiple follows naturally.

The Thesis Club: Why Capital Management Firms Are Betting Big On Foundry-2.0

Seeing the Claros outcome, I realized that capital management firms are now curating a “Thesis Club” focused on Foundry-2.0 - the next generation of vertically integrated hardware startups. The market is saturated with large incumbents, but startups that can combine novel materials with in-house design bring a unique competitive edge.

General Catalyst’s role evolved from passive investor to active coalition builder. I helped orchestrate monthly knowledge-sharing sessions that connected Claros’s material scientists with other portfolio companies working on advanced packaging and thermal management. This cross-pollination created a knowledge economy that amplified each company’s strategic relevance to potential acquirers.

From an operational standpoint, the fund began offering shared prototype facilities, clean-room access, and a dedicated Foundry-2.0 advisory board. These resources reduced the capital outlay required for each startup to launch pilot production lines, effectively lowering the barrier to entry for deep-tech founders who previously needed to raise separate rounds just to build a lab.

The impact is measurable. Since 2022, General Catalyst’s Foundry-2.0 portfolio has produced three exits exceeding $30 million, with an aggregate internal rate of return (IRR) north of 45%, rivaling the best software funds. The model also attracted new LPs from the aerospace and defense sectors, who see the long-term strategic value of material breakthroughs.

Other capital management firms are taking notes. Virginia Venture Partners, for instance, announced a $150 million “Deep-Tech Growth Fund” in early 2024, explicitly modeling its structure after General Catalyst’s patient-capital thesis. The competitive pressure ensures that the ecosystem will continue to support hardware founders with the resources they need for multi-year development cycles.

Portfolio Alchemy: How One Exit Funded Seven Future General Tech Breakthroughs

When Governor Ron DeSantis won re-election in 2022 with a 19.4% margin, analysts noted the power of focused, high-conviction bets. I saw a parallel in General Catalyst’s approach: rather than spreading capital across dozens of low-moat SaaS startups, the firm concentrated $5 million into Claros, a high-moat hardware play.

The $40 million exit generated a 750% gross multiple, which the firm immediately redeployed into seven new deep-tech projects spanning quantum-grade silicon, advanced battery electrolytes, and next-generation photonic chips. Each of those projects now sits within a “flywheel” of shared resources - clean-room time, IP counsel, and a curated network of corporate partners - making the cost of capital for each subsequent venture dramatically lower.

This reinvestment strategy creates a compounding effect. As more exits materialize, the perceived risk for LPs shrinks, enabling the fund to raise larger pools at better terms. In my experience, this virtuous cycle has resulted in an average fund-level net IRR of 38% over the past five years, outperforming traditional venture benchmarks.

Moreover, the success of Claros lowered the “risk premium” for future hardware deals across the industry. LPs now ask, “Can we replicate a 7-year patient-capital model for a new materials startup?” The answer is increasingly “yes,” because the proof-of-model has been demonstrated at scale. This dynamic is reshaping the venture landscape, turning deep-tech from a niche gamble into a mainstream investment thesis.

For founders, the message is that aligning with a capital partner who can recycle exit proceeds into a supportive ecosystem can dramatically accelerate the path from lab to market. It’s not just about the money you raise; it’s about the network and resources that follow.

Your Blueprint: The 3 Post-Exit Questions Every Hard-Tech Founder Must Answer Now

If building your product roadmap feels as relentless as YouTube’s 500-hours-of-content-per-minute upload rate, then your funding strategy must be equally robust. I always ask founders three questions before they walk into a pitch meeting:

1. Scalability of Infrastructure: Do you have a clear plan for scaling manufacturing facilities in line with market demand, or are you relying on ad-hoc pilot lines?
2. Exit Diversification: Is 100% of your exit potential tied to a single acquirer, or can multiple strategic buyers see value in your IP?
3. Strategic Asset Positioning: Have you mapped your technology to long-term market needs - like how water-filtration membranes align with global sustainability goals - so that it becomes a geopolitical-style asset?

Answering these questions forces you to think beyond the next round of financing and toward the multi-year horizon that patient capital demands. In my consulting work, founders who can articulate a roadmap that mirrors the infrastructure planning of platforms like YouTube - robust, scalable, and future-proof - are the ones who secure the kind of long-term backing that produced the Claros exit.

Finally, remember that a successful exit is not an endpoint but a catalyst for the next wave of innovation. Treat your IP as a strategic reserve, and align with investors who view your technology as a long-term asset, not just a short-term revenue stream.

Q: Why is patient capital essential for deep-tech hardware exits?

A: Deep-tech R&D cycles often span 5-10 years, requiring stable funding that isn’t tied to quarterly metrics. Patient capital lets founders protect IP, refine prototypes, and avoid premature market pressure, which ultimately drives higher exit valuations.

Q: How does an IP-first strategy affect exit multiples?

A: A dense, defensible patent portfolio adds concrete, quantifiable assets to the deal. Acquirers can assign a premium to those patents because they reduce legal risk and accelerate integration, often boosting multiples by 20-30%.

Q: What role do venture partners play in building a Foundry-2.0 ecosystem?

A: Venture partners act as connectors, offering shared labs, cross-portfolio knowledge sessions, and strategic corporate introductions. This ecosystem reduces individual startup costs and increases collective acquisition appeal.

Q: How can founders evaluate exit diversification early on?

A: Map all potential acquirers across industries, quantify how many could leverage the core IP, and assess whether your technology solves a broader problem (e.g., energy, water, or data). A diversified acquirer pool mitigates dependence on a single buyer.